Detalhe da pesquisa
1.
circEZH2E2 /E3 is a dual suppressor of miR363/miR708 to promote EZH2 expression and prostate cancer progression.
Cancer Sci
; 114(4): 1378-1395, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36519785
2.
SOX9 and HMGB3 co-operatively transactivate NANOG and promote prostate cancer progression.
Prostate
; 83(5): 440-453, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541373
3.
The roles of mutated SPINK1 gene in prostate cancer cells.
Mutagenesis
; 37(5-6): 238-247, 2022 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36112498
4.
MicroRNA181c inhibits prostate cancer cell growth and invasion by targeting multiple ERK signaling pathway components.
Prostate
; 78(5): 343-352, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29341215
5.
[Knocking-out of HIF1α gene by CRISPR/cas9 inhibits proliferation and invasiveness of prostate cancer DU145 cells].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
; 35(2): 160-164, 2018 Apr 10.
Artigo
em Zh
| MEDLINE | ID: mdl-29652983
6.
[Prognostic Significance of ERG Gene Rearrangement and Protein Expression in Prostate Cancer].
Sichuan Da Xue Xue Bao Yi Xue Ban
; 48(1): 66-70, 2017 Jan.
Artigo
em Zh
| MEDLINE | ID: mdl-28612561
7.
The expression profile and prognostic value of SPINK1 in initially diagnosed bone metastatic prostate cancer.
Prostate
; 76(9): 823-33, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27159572
8.
Atypical metanephric adenoma: Shares similar histopathological features and molecular changes of metanephric adenoma and epithelial-predominant Wilms' tumor.
Front Oncol
; 12: 1020456, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36313688
9.
Inflammatory myofibroblastic lung tumor transforming into intracranial desmoplastic noninfantile ganglioglioma: A case report and literature review.
Medicine (Baltimore)
; 97(40): e12668, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30290651
10.
IDH1/2 gene hotspot mutations in central nervous system tumours: analysis of 922 Chinese patients.
Pathology
; 48(7): 675-683, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27780605
11.
SOX9 was involved in TKIs resistance in renal cell carcinoma via Raf/MEK/ERK signaling pathway.
Int J Clin Exp Pathol
; 8(4): 3871-81, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26097571